Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Ocrelizumab may cause pancreatitis in some patients.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.